Nomura Holdings
STOK icon

Nomura Holdings’s Stoke Therapeutics STOK Stock Holding History

Nomura Holdings’s Portfolio STOK Stock Details STOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-20,400
Closed -$1.26M – 2256
2020
Q4 		$1.26M Buy
+20,400
New +$935K ﹤0.01% 961

Other funds holding STOK

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Nomura Holdings's STOK Position: Q1 2026 in Review

Nomura Holdings reduced its Stoke Therapeutics (STOK) stake by 39% in Q1 2026, selling an estimated $573K and leaving 26,891 shares worth $876K. The position accounts for ﹤0.01% of the portfolio, ranked #1207.

Nomura Holdings first reported a position in STOK in Q3 2025 and has held it in 3 quarters since. The position peaked at $1.91M in Q3 2025. 196 funds tracked by Wall St. Rank hold STOK as of Q1 2026.

  • Nomura Holdings held 26,891 shares of Stoke Therapeutics worth $876K as of Q1 2026.
  • Nomura Holdings sold 17,461 Stoke Therapeutics shares in Q1 2026, an estimated $573K.
  • Stoke Therapeutics made up ﹤0.01% of Nomura Holdings's portfolio in Q1 2026, its #1207 holding.
  • Nomura Holdings first reported a position in Stoke Therapeutics in Q3 2025 and has held it in 3 quarters since.
  • Nomura Holdings's Stoke Therapeutics position peaked at $1.91M in Q3 2025.
  • 196 funds tracked by Wall St. Rank held Stoke Therapeutics as of Q1 2026.

Based on Nomura Holdings's 13F filing for Q1 2026, filed 15 May 2026.